Trial Profile
A Study to Evaluate the Pharmacokinetic Patterns of Risperidone-associated Adverse Drug Reactions
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Jul 2016
Price :
$35
*
At a glance
- Drugs Risperidone (Primary)
- Indications Psychiatric disorders
- Focus Adverse reactions; Pharmacokinetics
- 13 Jul 2016 New trial record
- 04 Jul 2016 Results published in the European Journal of Clinical Pharmacology